Clinical trials with IDEC-114 begin following favorable safety and pharmacokinetic results in chimps Nov. 29, 1999 No Comments
Topical formulations of ABT-281 in development according to 1999 AAPS presentations Nov. 29, 1999 No Comments
Schering AG will handle marketing and sales of Levulan for Dusa; U.S. launch in sight Nov. 29, 1999 No Comments
Preliminary phase III results disappointing for Anogesic as anal fissure therapy Nov. 26, 1999 No Comments
Chromanone derivatives for androgen-dependent and other disorders disclosed by Novartis Nov. 16, 1999 No Comments